{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:28:07Z","timestamp":1793255287774,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,8,31]],"date-time":"2006-08-31T00:00:00Z","timestamp":1156982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1186\/1477-7525-4-59","type":"journal-article","created":{"date-parts":[[2006,8,31]],"date-time":"2006-08-31T18:18:29Z","timestamp":1157048309000},"source":"Crossref","is-referenced-by-count":131,"title":["Hydroxyurea and sickle cell anemia: effect on quality of life"],"prefix":"10.1186","volume":"4","author":[{"given":"Samir K","family":"Ballas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca B","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron A","family":"Waclawiw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Swerdlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R","family":"Eckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles H","family":"Pegelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabel","family":"Koshy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duane R","family":"Bonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,8,31]]},"reference":[{"key":"293_CR1","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1001\/jama.283.13.1740","volume":"283","author":"SD Fihn","year":"2000","unstructured":"Fihn SD: The quest to quantify quality. JAMA 2000, 283: 1740\u20131742. 10.1001\/jama.283.13.1740","journal-title":"JAMA"},{"key":"293_CR2","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1001\/jama.1989.03430070055030","volume":"262","author":"AL Stewart","year":"1989","unstructured":"Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, McGlynn EA, Ware JE: Functional status and well being of patients with chronic conditions. JAMA 1989, 262: 907\u2013913. 10.1001\/jama.262.7.907","journal-title":"JAMA"},{"key":"293_CR3","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.1989.03430070091038","volume":"262","author":"D Riesenberg","year":"1989","unstructured":"Riesenberg D, Glass RM: The Medical outcomes study. JAMA 1989, 262: 943. 10.1001\/jama.262.7.943","journal-title":"JAMA"},{"key":"293_CR4","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1002\/1097-0142(19890601)63:11<2321::AID-CNCR2820631142>3.0.CO;2-T","volume":"63","author":"BR Ferrell","year":"1989","unstructured":"Ferrell BR, Wisdom C, Wenzl C: Quality of life as an outcome variable in the management of cancer pain. Cancer 1989, 63: 2321\u20132327. Publisher Full Text 10.1002\/1097-0142(19890601)63:11<2321::AID-CNCR2820631142>3.0.CO;2-T","journal-title":"Cancer"},{"key":"293_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJM199107043250103","volume":"325","author":"O Platt","year":"1991","unstructured":"Platt O, Thorington BD, Brambilla DJ, Milner PF, Rosse W, Vichinsky E, Kinney TR: Pain in sickle cell disease: rates and risk factors. N Engl J Med 1991, 325: 11\u201316.","journal-title":"N Engl J Med"},{"key":"293_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0021-9681(85)90033-5","volume":"38","author":"MD Farber","year":"1985","unstructured":"Farber MD, Koshy M, Kinney TR, the Cooperative Group: Cooperative study of sickle cell disease: demographic and socioeconomic characteristics of patients and families with sickle cell disease. J Chronic Dis 1985, 38: 495\u2013505. 10.1016\/0021-9681(85)90033-5","journal-title":"J Chronic Dis"},{"key":"293_CR7","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","volume":"330","author":"O Platt","year":"1994","unstructured":"Platt O, Brambilla DJ, Rosse W, Milner PF, Castro O, Steinberg MH, Klug PP: Mortality in sickle cell disease: Life expectancy and risk factors for early death. N Engl J Med 1994, 330: 1639\u20131644. 10.1056\/NEJM199406093302303","journal-title":"N Engl J Med"},{"key":"293_CR8","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","volume":"332","author":"S Charache","year":"1995","unstructured":"Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR, the Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia: Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995, 332: 1317\u20131322. 10.1056\/NEJM199505183322001","journal-title":"N Engl J Med"},{"key":"293_CR9","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1097\/00005792-199611000-00002","volume":"75","author":"S Charache","year":"1996","unstructured":"Charache S, Barton FB, Moore RD, Terrin ML, Steinberg MH, Dover GJ, Ballas SK, McMahon RP, Castro O, Orringer EP: Hydroxyurea and sickle cell anemia: clinical utility of a myelosuppressive \"switching\" agent. Medicine 1996, 75: 300\u2013326. 10.1097\/00005792-199611000-00002","journal-title":"Medicine"},{"key":"293_CR10","unstructured":"Ware JE, Snow KK, Kosinski M, Gandek B: SF-36 Health Survey Manual and Interpretation."},{"key":"293_CR11","unstructured":"How To Score The SF-36 Health Survey Boston Medical Outcomes Trust 1993."},{"key":"293_CR12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/140349488201000204","volume":"10","author":"JO Hornquist","year":"1982","unstructured":"Hornquist JO: The concept of quality of life. Scand J Soc Med 1982, 10: 57\u201361.","journal-title":"Scand J Soc Med"},{"key":"293_CR13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/140349489001800111","volume":"18","author":"JO Hornquist","year":"1989","unstructured":"Hornquist JO: Quality of life: concept and assessment. Scand J Soc Med 1989, 18: 69\u201379.","journal-title":"Scand J Soc Med"},{"key":"293_CR14","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood.V89.3.1078","volume":"89","author":"MH Steinberg","year":"1997","unstructured":"Steinberg MH, Lu ZH, Barton FB, Terrin MJ, Charache S, Dover GJ, the Multicenter Study of Hydroxyurea in Sickle Cell Anemia Group: Fetal hemoglobin in Sickle Cell Anemia: determinants of response to hydroxyurea. Blood 1997, 89: 1078\u20131088.","journal-title":"Blood"},{"key":"293_CR15","first-page":"15","volume":"4","author":"KF Woods","year":"1997","unstructured":"Woods KF, Miller MD, Johnson MH, Tracy A, Kutlar A, Cassel CK: Functional status and well being in adults with Sickle Cell Disease. JCOM 1997, 4: 15\u201321.","journal-title":"JCOM"},{"key":"293_CR16","first-page":"377","volume":"29","author":"DA Revicki","year":"1989","unstructured":"Revicki DA: Health-related quality of life in the evaluation of medical therapy for chronic illness. J Fam Pract 1989, 29: 377\u2013380.","journal-title":"J Fam Pract"},{"key":"293_CR17","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/j.1464-5491.1991.tb01696.x","volume":"8","author":"BR Hanestad","year":"1991","unstructured":"Hanestad BR, Albrektsen G: Quality of life: perceived difficulties in adherence to a diabetes regimen, and blood glucose control. Diabet Med 1991, 8: 759\u2013764.","journal-title":"Diabet Med"},{"key":"293_CR18","first-page":"1842","volume":"50","author":"Y Harati","year":"1998","unstructured":"Harati Y, Gooch C, Swenson M, Edelman S, Greene D, Raskin P, Donofrio P, Cornblath D, Sachleo R, Siu CO, Kamin M: Double blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neuropathy 1998, 50: 1842\u20131846.","journal-title":"Neuropathy"},{"key":"293_CR19","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1001\/jama.280.21.1837","volume":"280","author":"M Rowbotham","year":"1998","unstructured":"Rowbotham M, Harden N, Stacey B, Bernstein PS, Magnus-Miller L, the Gabapentin post herpetic Neuralgia Study Group: Gabapentin for the treatment of postherpetic neuralgia. A randomized controlled trial. JAMA 1998, 280: 1837\u20131842. 10.1001\/jama.280.21.1837","journal-title":"JAMA"},{"key":"293_CR20","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1001\/jama.280.21.1831","volume":"280","author":"M Backonja","year":"1998","unstructured":"Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonsecs V, Hes M, LaMoreaux L, Garofalo E, the Gabapentin Diabetic Neuropathy Study Group: Gabapentin for the Symptomatic treatment of painful Neuropathy in patients with Diabetes Mellitus. JAMA 1998, 280: 1831\u20131836. 10.1001\/jama.280.21.1831","journal-title":"JAMA"},{"key":"293_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/adc.75.3.199","volume":"75","author":"P Fuggle","year":"1996","unstructured":"Fuggle P, Shand PA, Gill LJ, Davies SC: Pain, quality of life, and coping in sickle cell disease. Arch Dis Child 1996, 75: 199\u2013203.","journal-title":"Arch Dis Child"},{"key":"293_CR22","first-page":"2049","volume":"143","author":"AP Kater","year":"1999","unstructured":"Kater AP, Hejboer H, Peters M, Vogels T, Prins MH, Heymans HS: Quality of life in children with sickle cell disease in Amsterdam area (Dutch) Netherlands. Ned Tijdschr Geneeskd 1999, 143: 2049\u20132053.","journal-title":"Ned Tijdschr Geneeskd"},{"key":"293_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1348\/135910702760213715","volume":"7","author":"KA Anie","year":"2002","unstructured":"Anie KA, Steptoe A, Bevan DH: Sickle cell disease: Pain, coping and quality of life in a study of adults in the UK. Br J Health Psychol 2002, 7: 331\u2013334. 10.1348\/135910702760213715","journal-title":"Br J Health Psychol"},{"key":"293_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1477-7525-3-50","volume":"3","author":"DK McClish","year":"2005","unstructured":"McClish DK, Penberthy LT, Bovbjerg VE, Roberts JD, Aisiku IP, Levenson JL, Roseff SD, Smith WR: Health related quality of life in sickle cell patients: the PiSCES project. Health Qual Life Outcomes 2005, 3: 50. 10.1186\/1477-7525-3-50","journal-title":"Health Qual Life Outcomes"},{"key":"293_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1002\/ajh.2830320206","volume":"32","author":"SK Ballas","year":"1989","unstructured":"Ballas SK, Dover GJ, Charache S: Effect of Hydroxyurea on the rheological properties of sickle cell erythrocytes in vivo. Am J Hematol 1989, 32: 104\u2013111.","journal-title":"Am J Hematol"},{"key":"293_CR26","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1182\/blood.V79.10.2555.2555","volume":"79","author":"S Charache","year":"1992","unstructured":"Charache S, Dover GJ, Moore RD, Eckert S, Ballas SK, Koshy M, Milner PFA, Orringer EP, Phillips G Jr, Platt OS, Thomas GH: Hydroxyurea: Effect on hemoglobin F production in patients with sickle cell anemia. Blood 1992, 79: 2555\u20132565.","journal-title":"Blood"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7525-4-59.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1477-7525-4-59\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7525-4-59.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,18]],"date-time":"2020-04-18T03:37:29Z","timestamp":1587181049000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/1477-7525-4-59"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,31]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["293"],"URL":"https:\/\/doi.org\/10.1186\/1477-7525-4-59","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,31]]},"article-number":"59"}}